A patient with a history of bleeding disorders is found to have a deficiency of plasminogen activator inhibitor-1 (PAI-1). What is the likely consequence of this deficiency?

PAI-1 inhibits plasminogen activators, which are involved in fibrinolysis. A deficiency of PAI-1 would lead to increased fibrinolysis, resulting in an increased risk of bleeding.